Brief: IRLAB Q3 Sales SEK 18.8 Million
29/10/2025 06:00
Oct 29 (Reuters) - IRLAB Q3 operating cash flow SEK 5.3 million. Q3 adjusted EPS SEK -0.26 Q3 EBIT SEK -17.2 million
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK165.12m
- SEK155.10m
- SEK57.46m